BlackRock
PRCT icon

BlackRock’s Procept Biorobotics PRCT Stock Holding History

BlackRock’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110M Buy
4,869,828
+507,826
+12% +$12.7M ﹤0.01% 2178
2026
Q1 		$109M Buy
4,362,002
+14,969
+0.3% +$422K ﹤0.01% 2048
2025
Q4 		$137M Buy
4,347,033
+126,544
+3% +$4.2M ﹤0.01% 1913
2025
Q3 		$151M Buy
4,220,489
+12,260
+0.3% +$560K ﹤0.01% 1839
2025
Q2 		$242M Buy
4,208,229
+331,841
+9% +$18.8M ﹤0.01% 1510
2025
Q1 		$226M Buy
3,876,388
+26,699
+0.7% +$1.82M ﹤0.01% 1527
2024
Q4 		$310M Buy
3,849,689
+205,530
+6% +$17.6M 0.01% 1407
2024
Q3 		$292M Buy
3,644,159
+158,668
+5% +$11.3M 0.01% 1442
2024
Q2 		$213M Buy
3,485,491
+192,947
+6% +$11.5M ﹤0.01% 1567
2024
Q1 		$163M Sell
3,292,544
-65,094
-2% -$3.1M ﹤0.01% 1778
2023
Q4 		$141M Buy
3,357,638
+413,629
+14% +$14.1M ﹤0.01% 1881
2023
Q3 		$96.6M Buy
2,944,009
+363,883
+14% +$12.4M ﹤0.01% 2012
2023
Q2 		$91.2M Buy
2,580,126
+684,194
+36% +$22.6M ﹤0.01% 2101
2023
Q1 		$53.8M Sell
1,895,932
-5,322
-0.3% -$188K ﹤0.01% 2392
2022
Q4 		$79M Buy
1,901,254
+92,320
+5% +$3.96M ﹤0.01% 2171
2022
Q3 		$75M Buy
1,808,934
+545,116
+43% +$21.7M ﹤0.01% 2146
2022
Q2 		$41.3M Buy
1,263,818
+911,027
+258% +$33.1M ﹤0.01% 2616
2022
Q1 		$12.3M Buy
352,791
+31,486
+10% +$758K ﹤0.01% 3468
2021
Q4 		$8.04M Buy
321,305
+301,305
+1,507% +$11.1M ﹤0.01% 3791
2021
Q3 		$763K Buy
+20,000
New +$768K ﹤0.01% 4640

Other funds holding PRCT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock's PRCT Position: Q2 2026 in Review

BlackRock increased its Procept Biorobotics (PRCT) stake by 12% in Q2 2026, buying an estimated $12.7M and bringing the position to 4,869,828 shares worth $110M. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

BlackRock first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $310M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • BlackRock held 4,869,828 shares of Procept Biorobotics worth $110M as of Q2 2026.
  • BlackRock bought 507,826 Procept Biorobotics shares in Q2 2026, an estimated $12.7M.
  • Procept Biorobotics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2178 holding.
  • BlackRock first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's Procept Biorobotics position peaked at $310M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.